Metropolitan Life Insurance CO Fibrogen Inc Transaction History

Metropolitan Life Insurance CO

$281 Million
Q3 2024

50 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$0.73 - $2.73 $3,671 - $13,731	5,030 New	5,030 $11,000
Q1 2023 May 15, 2023	SELL	$15.95 - $25.18 $14,721 - $23,241	-923 Reduced 15.98%	4,854 $90,000
Q4 2022 Jun 14, 2023	BUY	$13.27 - $17.73 $12,248 - $16,364	923 Added 19.02%	5,777 $92.5 Million
Q3 2022 Jun 14, 2023	BUY	$11.4 - $14.6 $10,522 - $13,475	923 Added 19.02%	5,777 $75.2 Million
Q2 2022 Jun 20, 2023	BUY	$7.94 - $12.96 $7,328 - $11,962	923 Added 19.02%	5,777 $61,000
Q1 2022 Jun 20, 2023	BUY	$12.02 - $16.79 $11,094 - $15,497	923 Added 19.02%	5,777 $69,000
Q1 2022 Mar 30, 2023	SELL	$12.02 - $16.79 $168,147 - $234,875	-13,989 Reduced 70.77%	5,777 $69,000
Q1 2022 May 12, 2022	SELL	$12.02 - $16.79 $168,147 - $234,875	-13,989 Reduced 70.77%	5,777 $69,000
Q4 2021 Jun 21, 2023	BUY	$9.93 - $15.39 $148,076 - $229,495	14,912 Added 307.21%	19,766 $278,000
Q4 2021 Mar 30, 2023	SELL	$9.93 - $15.39 $7,725 - $11,973	-778 Reduced 3.79%	19,766 $278,000
Q4 2021 Feb 15, 2022	SELL	$9.93 - $15.39 $7,725 - $11,973	-778 Reduced 3.79%	19,766 $279,000
Q3 2021 Jun 21, 2023	BUY	$10.18 - $26.64 $159,724 - $417,981	15,690 Added 323.24%	20,544 $209,000
Q3 2021 Mar 30, 2023	SELL	$10.18 - $26.64 $40,658 - $106,400	-3,994 Reduced 16.28%	20,544 $209,000
Q3 2021 Nov 15, 2021	SELL	$10.18 - $26.64 $40,658 - $106,400	-3,994 Reduced 16.28%	20,544 $210,000
Q2 2021 Jun 21, 2023	BUY	$18.57 - $35.68 $365,531 - $702,325	19,684 Added 405.52%	24,538 $653,000
Q2 2021 Mar 30, 2023	BUY	$18.57 - $35.68 $29,284 - $56,267	1,577 Added 6.87%	24,538 $653,000
Q2 2021 Aug 16, 2021	BUY	$18.57 - $35.68 $455,243 - $874,695	24,515 Added 106586.96%	24,538 $653,000
Q1 2021 Jun 26, 2023	BUY	$31.0 - $55.72 $561,317 - $1.01 Million	18,107 Added 373.03%	22,961 $797 Million
Q1 2021 Mar 30, 2023	SELL	$31.0 - $55.72 $29,264 - $52,599	-944 Reduced 3.95%	22,961 $796,000
Q1 2021 May 14, 2021	SELL	$31.0 - $55.72 $740,342 - $1.33 Million	-23,882 Reduced 99.9%	23 $797,000
Q4 2020 Jun 22, 2023	BUY	$37.09 - $48.97 $706,601 - $932,927	19,051 Added 392.48%	23,905 $886,000
Q3 2020 Jun 26, 2023	BUY	$40.47 - $45.5 $770,993 - $866,820	19,051 Added 392.48%	23,905 $982,000
Q3 2020 Mar 30, 2023	SELL	$40.47 - $45.5 $56,415 - $63,427	-1,394 Reduced 5.51%	23,905 $982,000
Q3 2020 Nov 13, 2020	SELL	$40.47 - $45.5 $56,415 - $63,427	-1,394 Reduced 5.51%	23,905 $983,000
Q2 2020 Jun 26, 2023	BUY	$32.57 - $42.83 $665,893 - $875,659	20,445 Added 421.2%	25,299 $1.03 Million
Q2 2020 Mar 30, 2023	BUY	$32.57 - $42.83 $55,629 - $73,153	1,708 Added 7.24%	25,299 $1.03 Million
Q2 2020 Aug 14, 2020	BUY	$32.57 - $42.83 $55,629 - $73,153	1,708 Added 7.24%	25,299 $1.03 Million
Q1 2020 Jul 12, 2023	BUY	$23.3 - $45.96 $440,393 - $868,689	18,901 Added 389.39%	23,755 $825,000
Q1 2020 Mar 30, 2023	SELL	$23.3 - $45.96 $26,422 - $52,118	-1,134 Reduced 4.59%	23,591 $819,000
Q1 2020 May 15, 2020	SELL	$23.3 - $45.96 $26,422 - $52,118	-1,134 Reduced 4.59%	23,591 $820,000
Q4 2019 Jul 12, 2023	BUY	$34.58 - $48.06 $687,139 - $955,000	19,871 Added 409.37%	24,725 $1.06 Million
Q4 2019 Mar 30, 2023	SELL	$34.58 - $48.06 $17,601 - $24,462	-509 Reduced 2.02%	24,725 $1.06 Million
Q4 2019 Feb 14, 2020	SELL	$34.58 - $48.06 $17,601 - $24,462	-509 Reduced 2.02%	24,725 $1.06 Million
Q3 2019 Jul 12, 2023	BUY	$36.98 - $48.45 $753,652 - $987,411	20,380 Added 419.86%	25,234 $933,000
Q3 2019 Mar 30, 2023	BUY	$36.98 - $48.45 $40,899 - $53,585	1,106 Added 4.58%	25,234 $933,000
Q3 2019 Nov 14, 2019	BUY	$36.98 - $48.45 $40,899 - $53,585	1,106 Added 4.58%	25,234 $933,000
Q2 2019 Jul 12, 2023	BUY	$35.13 - $55.53 $677,095 - $1.07 Million	19,274 Added 397.07%	24,128 $1.09 Million
Q1 2019 Jul 13, 2023	BUY	$42.83 - $59.91 $825,505 - $1.15 Million	19,274 Added 397.07%	24,128 $1.31 Million
Q1 2019 Mar 30, 2023	BUY	$42.83 - $59.91 $785,973 - $1.1 Million	18,351 Added 317.66%	24,128 $1.31 Million
Q1 2019 May 16, 2019	SELL	$42.83 - $59.91 $1.82 Million - $2.54 Million	-42,451 Reduced 63.76%	24,128 $1.31 Million
Q1 2019 May 15, 2019	BUY	$42.83 - $59.91 $1.81 Million - $2.53 Million	42,166 Added 172.72%	66,579 $4.79 Million
Q4 2018 Jul 13, 2023	BUY	$37.97 - $60.16 $742,655 - $1.18 Million	19,559 Added 402.95%	24,413 $1.13 Million
Q4 2018 Feb 14, 2019	BUY	$37.97 - $60.16 $726,631 - $1.15 Million	19,137 Added 362.72%	24,413 $1.13 Million
Q3 2018 Jul 13, 2023	BUY	$56.3 - $67.25 $1.08 Million - $1.29 Million	19,236 Added 396.29%	24,090 $1.46 Billion
Q3 2018 Nov 14, 2018	SELL	$56.3 - $67.25 $1.06 Million - $1.27 Million	-18,814 Reduced 78.1%	5,276 $321,000
Q2 2018 Aug 15, 2018	BUY	$44.9 - $64.95 $93,885 - $135,810	2,091 Added 9.5%	24,090 $0
Q1 2018 May 15, 2018	BUY	$45.35 - $61.65 $24,035 - $32,674	530 Added 2.47%	21,999 $0
Q4 2017 Feb 15, 2018	SELL	$41.95 - $60.1 $973,533 - $1.39 Million	-23,207 Reduced 51.95%	21,469 $1.02 Million
Q3 2017 Nov 14, 2017	BUY	$33.4 - $53.9 $151,869 - $245,083	4,547 Added 11.33%	44,676 $2.4 Million
Q2 2017 Aug 14, 2017	BUY	N/A	40,129	40,129 $1.3 Million

Others Institutions Holding FGEN

# of Institutions

Shares Held

47.1M

Call Options Held

387K

Put Options Held

672K

View Full List

About FIBROGEN INC

Ticker FGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,741,200
Market Cap $31.9M
Description
FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic k...

More about FGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.

Account